You have 9 free searches left this month | for more free features.

City

Austin (1)

Neuss (1)

Stockholm (1)

Condition

Diabetes Mellitus, Type 1 (1)

Type 1 Diabetes Mellitus (1)

Type1 Diabetes Mellitus (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Adocia (1)

Novo Nordisk A/S (1)

Texas Diabetes & Endocrinology, P.A. (1)

Collaborator

Intervention

fiasp® (3)

670g hybrid closed loop continuous subcutaneous insulin infusion system (1)

biochaperone® insulin lispro (1)

novolog® (1)

novorapid® (1)

Study Documents

Intervention Type

drug (3)

device (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

fiasp®

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Effect of Fiasp® in Type 1 Diabetes Treatment

Completed

Diabetes Mellitus, Type 1

Fiasp®

Stockholm, Sweden

Novo Nordisk Investigational Site

Apr 6, 2022

Type 1 Diabetes Trial in Austin (Fiasp®, Novolog®, 670G hybrid closed loop continuous subcutaneous insulin infusion system)

Completed

Has Results

Type 1 Diabetes Mellitus

Fiasp®
+2 more

Austin, Texas

Texas Diabetes & Endocrinology

Sep 9, 2020

Type1 Diabetes Trial in Neuss (BioChaperone® insulin lispro, Fiasp®, Novorapid®)

Completed

Type1 Diabetes Mellitus

BioChaperone® insulin lispro
+2 more

Neuss, Germany

Profil Institut für Stoffwechselforschung GmbH

Dec 11, 2017